Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult-Onset Still´s Disease”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Testing effectiveness (Phase 2)Ended earlyNCT02204293
What this trial is testing

Canakinumab for Treatment of Adult-onset Still's Disease

Who this might be right for
Adult-Onset Still´s Disease
Charite University, Berlin, Germany 36
Testing effectiveness (Phase 2)Looking for participantsNCT07203001
What this trial is testing

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Who this might be right for
Still´s Disease
Novartis Pharmaceuticals 20
Not applicableLooking for participantsNCT07191444
What this trial is testing

Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
Ruijin Hospital 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation